We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




A Nanocomposite Endows Antimicrobial Properties to Diverse Materials

By HospiMedica staff writers
Posted on 11 Dec 2007
An innovative silver nanocomposite technology with antimicrobial properties can be readily incorporated into a variety of substrates, including synthetic fibers and plastics.

The HeiQ-Silver powder is a composite structure composed of silver nanoparticles supported throughout a matrix of amorphous silicon dioxide (SiO2). More...
The agglomerated SiO2 matrix forms a particle with a typical size of 0.1 to 1 ìm; each silica particle contains many smaller silver metal particles each with a typical size between 5 and 20 nanometers. These silver particles are found on the surface of the silica and also embedded throughout the silica structure. The silver nanoparticles act as a reservoir for release of silver ions (Ag+) that are the active agent against bacteria.

The presence of both surface and embedded silver particles gives the material a combination of immediate antimicrobial activity combined with long-term durability that the fine size of the silica particles allows them. The antimicrobial effect of the silver can provide beneficial functionality in a broad range of applications, including synthetic fibers, textile finishing, plastic parts and moldings, paints and coatings, medical applications, and cosmetics. The The HeiQ-Silver powder is manufactured by HeiQ Materials (Bad Zurzach, Switzerland).

While metallic silver is historically recognized as being antimicrobial, it is not the pure silver that is active, but the liberated silver ions. The effect of silver ions stems from three key mechanisms: The binding and damage to the bacterial cell surface; inhibition of respiration by suppressing transport of vital Ca2+ and Zn2+ ions across the cell membrane; and binding strongly to electron donor groups on constituent bacterial molecules containing sulfur, oxygen, or nitrogen.


Related Links:
HeiQ Materials

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.